Product Surprises Street #VolatilityWatch

What happened?
There were around 106,000 Imvexxy prescriptions in the second quarter, which was 41% more than during the first three months of the year. Treatment's popularity seems to be accelerating: In July the company recorded 45,500 prescriptions bought and paid for.

TherapeuticsMD was expecting net rev. to reach between $4.5 million and $5.5 million in the second quarter, but surprised the street, recording $6.1 million. Management thinks the current market for Imvexxy exceeds $1.7 billion annually. Looking for re-evaluation of stock price into September.

Technical's:

• Bullish Harmonic Crab reversal at the 1.414 fib. extension level.
  
• #TXMD has been heavily shorted for awhile now, look for shorts trying to cover, to add on pullback(s).
  
• Looking for potential continuation trade.
  
• Oscillators are flashing "overbought" after parabolic move. I'm not reliant on these oscillator levels but this stock is a stock to WATCH!
  
• Be careful chasing at these levels (watch for 382-50 retracement: levels noted on chart)
  
• #TXMD seems to have now made a bottom. I will be looking to add on the dips.
  
  

Please like and follow so I can continue finding awesome trades. Thank you in advance =)

Tip #12: Fibonacci extension level between 1.272 - 1.414 are major psychological levels for "breathers" and reversals during uptrend/ downtrends.

Disclosure: I do not own #TXMD. I may buy/ sell within the next 72 hours. This is not a note to buy or sell, please do your homework before investing.